CompuGroup Medical Reports Decline in Revenue and EPS

CompuGroup Medical faces challenges as its revenues and EPS drop. The company reported revenues of approximately 1.154 billion euros for fiscal 2024, down from 1.188 billion euros in the previous year. Adjusted EPS fell to approximately 1.27 euros.

Date: 04-03-2025

AI Rating: 4

Revenue and Earnings Drop
CompuGroup Medical SE & Co. reported revenues of approximately 1.154 billion euros in fiscal 2024, showing a decline compared to approximately 1.188 billion euros the prior year. This decrease in revenue, approximately two percent year-on-year, could raise concerns among investors about the company's growth potential.

Additionally, the adjusted earnings per share (EPS) dropped to approximately 1.27 euros from approximately 2.06 euros, indicating a significant decline in profitability, which may negatively affect investor sentiment and stock performance. The substantial decrease in adjusted EBITDA by around 15 percent to approximately 224.6 million euros further emphasizes the challenges the company is facing.

Moreover, the proposal to pay only the legally required minimum dividend of 0.05 euros per share may disappoint dividend-seeking investors, thereby potentially affecting the stock price negatively. Overall, these financial indicators suggest that CompuGroup Medical is encountering significant operational difficulties, which could lead to bearish sentiments in the market regarding its stock.

Stocks: CMPUY